MUMBAI: Cipla has launched Yurpeak, its version of tirzepatide, marking a major push into the fast-growing market for obesity and type 2 diabetes treatments. The therapy,...
MUMBAI: When it comes to sharpening its data game, LatentView Analytics isn’t just adding numbers, it’s adding names that count. The AI-driven analytics and consulting firm...